Geometric Changes in the Parotid, Submandibular, and Thyroid Glands during Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Cohort Study

Authors

  • Wenyong Tan Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen 518100, China
  • Ming Yang Clinical Research Center, The Second Clinical College (Shenzhen People Hospital), Jinan University, Shenzhen 518020, China
  • Yong Dai Clinical Research Center, The Second Clinical College (Shenzhen People Hospital), Jinan University, Shenzhen 518020, China
  • Desheng Hu Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan 430079, China

DOI:

https://doi.org/10.30683/1927-7229.2020.09.06

Keywords:

Intensity-modulated radiotherapy (IMRT), nasopharyngeal carcinoma (NPC), organ at risk (OAR), thyroid, submandibular gland, parotid gland, geometric changes, volume reduction.

Abstract

Background: Intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) acts on the tumor and affects surrounding organs at risk (OARs). This study aimed to quantify the geometric changes in the parotid gland, the submandibular gland (SMG), and the thyroid, during the course of treatment. Methods: Twenty patients diagnosed with locally advanced NPC were consecutively enrolled, and received definitive chemoradiotherapy in 33 fractions over 6.5 weeks. Each patient underwent planning computed tomography (pCT) followed by six weekly repeat CTs (rCTs) without contrast enhancement. Each rCT was rigidly registered to its pCT. Changes in terms of volume, position, and shape of the OARs were assessed. Differences in left- and right-sided OARs were compared. Results: Radiation doses to the parotid, SMG, and thyroid were 32.12 ± 11.2 Gy (mean ± standard deviation SD), 25.46 ± 8.62 Gy, and 18.89 ± 10.24 Gy, respectively. Volume reductions of 28.6% ± 14.6% (mean ± SD), 26.6% ± 17.1%, and 12.3% ± 11.3% were observed in the parotid, SMG, and thyroid, respectively. Rate of volume loss for the parotid and SMG decreased from 1.6-1.7% per day in the first week to 0.5%-0.6% in the last week. Contrarily, not all thyroid lobes decreased in volume during treatment. The center of mass of the parotid shifted 2.0-2.6 mm medially; for the SMG and thyroid, a 0.1-0.5 mm medial shift was noted. The displacement in the anterior-posterior and cranial-caudal directions was < 0.6 mm. The 3-dimensional vector displacements of the parotid and SMG were 2.2-2.9 mm, and that of thyroid was 4.0-4.3 mm. The overlapping metrics of all three OARs decreased over time, and the shortest perpendicular distance increased from 1.5-1.8 mm in the first week to 2.4-2.5 mm in the last week. The geometric differences between weeks were statistically significant (P<0.05). Conclusions: The volume, position, and shape of the OARs changed significantly during IMRT for NPC. These geometric changes displayed a time association, suggesting the necessity to re-plan treatment for better sparing of these OARs.

References

Cmelak AJ. Current issues in combined modality therapy in locally advanced head and neck cancer. Critical reviews in oncology/hematology 2012; 84(2): 261-273. https://doi.org/10.1016/j.critrevonc.2012.04.004

Gregoire V, Langendijk JA, Nuyts S. Advances in Radiotherapy for Head and Neck Cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2015; 33(29): 3277-3284. https://doi.org/10.1200/JCO.2015.61.2994

Castadot P, Lee JA, Geets X, Gregoire V. Adaptive radiotherapy of head and neck cancer. Seminars in radiation oncology 2010; 20(2): 84-93. https://doi.org/10.1016/j.semradonc.2009.11.002

Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Seminars in radiation oncology 2012; 22(3): 233-244. https://doi.org/10.1016/j.semradonc.2012.03.008

Barker JL, Jr., Garden AS, Ang KK, O'Daniel JC, Wang H, Court LE, Morrison WH, Rosenthal DI, Chao KS, Tucker SL, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004; 59(4): 960-970. https://doi.org/10.1016/j.ijrobp.2003.12.024

Tan W, Li Y, Han G, Xu J, Wang X, Li Y, Hu D. Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. OncoTargets and therapy 2013; 6: 1719-1728. https://doi.org/10.2147/OTT.S53639

Tan W, Ye J, Xu R, Li X, He W, Wang X, Li Y, Hu D. The tumor shape changes of nasopharyngeal cancer during chemoradio-therapy: the estimated margin to cover the geometrical variation. Quant Imaging Med Surg 2016; 6(2): 115-124. https://doi.org/10.21037/qims.2016.03.07

Wang RH, Zhang SX, Zhou LH, Zhang GQ, Yu H, Lin XD, Lin S. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma. Bio-medical materials and engineering 2014; 24(1): 1217-1225. https://doi.org/10.3233/BME-130923

Cheng HC, Wu VW, Ngan RK, Tang KW, Chan CC, Wong KH, Au SK, Kwong DL. A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2012; 104(3): 317-323. https://doi.org/10.1016/j.radonc.2012.03.013

Tan W, Yang M, Sheng W, Hu D, Li X. Geometric Variations of the Clinical Target Volume in Neck Sublocations for Image-Guided Radiation Therapy of Nasopharyngeal Cancer. International Journal of Radiation Oncology Biology Physics 2018; 102(3): e354. https://doi.org/10.1016/j.ijrobp.2018.07.1071

Tan W, Wang Y, Yang M, Amos RA, Li W, Ye J, Gary R, Shen W, Hu D. Analysis of geometric variation of neck node levels during image-guided radiotherapy for nasopharyngeal carcinoma: recommended planning margins. Quant Imaging Med Surg 2018; 8(7): 637-647. https://doi.org/10.21037/qims.2018.08.03

Castadot P, Geets X, Lee JA, Christian N, Gregoire V. Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2010; 95(2): 209-217. https://doi.org/10.1016/j.radonc.2010.03.007

Veresezan O, Troussier I, Lacout A, Kreps S, Maillard S, Toulemonde A, Marcy PY, Huguet F, Thariat J. Adaptive radiation therapy in head and neck cancer for clinical practice: state of the art and practical challenges. Japanese journal of radiology 2016. https://doi.org/10.1007/s11604-016-0604-9

Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010; 76(3 Suppl): S58-63. https://doi.org/10.1016/j.ijrobp.2009.06.090

Murthy V, Narang K, Ghosh-Laskar S, Gupta T, Budrukkar A, Agrawal JP. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials. Head & neck 2014; 36(11): 1573-1580. https://doi.org/10.1002/hed.23482

Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, et al. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2012; 82(5): 1802-1808. https://doi.org/10.1016/j.ijrobp.2010.09.054

Feen Ronjom M. Radiation-induced hypothyroidism after treatment of head and neck cancer. Danish medical journal 2016; 63(3).

Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006; 64(2): 355-362. https://doi.org/10.1016/j.ijrobp.2005.07.957

Bhide SA, Davies M, Burke K, McNair HA, Hansen V, Barbachano Y, El-Hariry IA, Newbold K, Harrington KJ, Nutting CM. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys 2010; 76(5): 1360-1368. https://doi.org/10.1016/j.ijrobp.2009.04.005

van Herk M. Errors and margins in radiotherapy. Seminars in radiation oncology 2004; 14(1): 52-64. https://doi.org/10.1053/j.semradonc.2003.10.003

Kron T, Thomas J, Fox C, Thompson A, Owen R, Herschtal A, Haworth A, Tai KH, Foroudi F. Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2010; 95(2): 191-197. https://doi.org/10.1016/j.radonc.2010.01.010

Fotina I, Lutgendorf-Caucig C, Stock M, Potter R, Georg D. Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft

Heimann T, Meinzer HP. Statistical shape models for 3D medical image segmentation: a review. Medical image analysis 2009; 13(4): 543-563. https://doi.org/10.1016/j.media.2009.05.004

Castadot P, Lee JA, Parraga A, Geets X, Macq B, Gregoire V. Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2008; 89(1): 1-12. https://doi.org/10.1016/j.radonc.2008.04.010

Zhang H, Tan W, Sonke J-J. Effect of compressed sensing reconstruction on target and organ delineation in cone-beam CT of head-and-neck and breast cancer patients. Radiotherapy and Oncology 2014; 112(3): 413-417. https://doi.org/10.1016/j.radonc.2014.07.002

Pinna R, Campus G, Cumbo E, Mura I, Milia E. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Therapeutics and clinical risk management 2015; 11: 171-188. https://doi.org/10.2147/TCRM.S70652

Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 2009; 75(3): 924-932. https://doi.org/10.1016/j.ijrobp.2009.04.047

Ricchetti F, Wu B, McNutt T, Wong J, Forastiere A, Marur S, Starmer H, Sanguineti G. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011; 80(1): 161-168. https://doi.org/10.1016/j.ijrobp.2010.01.071

Chen C, Lin X, Pan J, Fei Z, Chen L, Bai P. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma? Japanese journal of radiology 2013; 31(9): 593-599. https://doi.org/10.1007/s11604-013-0225-5

Robar JL, Day A, Clancey J, Kelly R, Yewondwossen M, Hollenhorst H, Rajaraman M, Wilke D. Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007; 68(4): 1121-1130. https://doi.org/10.1016/j.ijrobp.2007.01.030

Loo H, Fairfoul J, Chakrabarti A, Dean JC, Benson RJ, Jefferies SJ, Burnet NG. Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt system. Clinical oncology 2011; 23(1): 40-47. https://doi.org/10.1016/j.clon.2010.09.003

Duma MN, Kampfer S, Schuster T, Winkler C, Geinitz H. Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft

Vasquez Osorio EM, Hoogeman MS, Al-Mamgani A, Teguh DN, Levendag PC, Heijmen BJ. Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. Int J Radiat Oncol Biol Phys 2008; 70(3): 875-882. https://doi.org/10.1016/j.ijrobp.2007.10.063

Ronjom MF, Brink C, Bentzen SM, Hegedus L, Overgaard J, Johansen J. Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2013; 109(2): 317-322. https://doi.org/10.1016/j.radonc.2013.06.029

Akgun Z, Atasoy BM, Ozen Z, Yavuz D, Gulluoglu B, Sengoz M, Abacioglu U. V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck. Radiation oncology 2014; 9: 104. https://doi.org/10.1186/1748-717X-9-104

Gregoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting C, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2014; 110(1): 172-181. https://doi.org/10.1016/j.radonc.2013.10.010

Gregoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2006; 79(1): 15-20. https://doi.org/10.1016/j.radonc.2006.03.009

van Kranen S, van Beek S, Rasch C, van Herk M, Sonke JJ. Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after offline CBCT guidance. Int J Radiat Oncol Biol Phys 2009; 73(5): 1566-1573. https://doi.org/10.1016/j.ijrobp.2008.11.035

Downloads

Published

2021-02-02

How to Cite

Wenyong Tan, Ming Yang, Yong Dai, & Desheng Hu. (2021). Geometric Changes in the Parotid, Submandibular, and Thyroid Glands during Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Cohort Study. Journal of Analytical Oncology, 9(1), 46–55. https://doi.org/10.30683/1927-7229.2020.09.06

Issue

Section

Articles